Dermira

company

About

Dermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.

  • 101 - 250

Details

Last Funding Type
Series C
Last Funding Money Raised
$51M
Industries
Biopharma,Biotechnology,Pharmaceutical
Founded date
Jan 1, 2010
Number Of Employee
101 - 250
Operating Status
Active

Dermira is a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients. Dermira’s portfolio of five product candidates targets significant market opportunities.

It was founded in 2010 and headquartered in Menlo Park, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$51M
Dermira has raised a total of $51M in funding over 2 rounds. Their latest funding was raised on Aug 19, 2014 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 19, 2014 Series C $51M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Dermira is funded by 1 investors. UCB are the most recent investors.
Investor Name Lead Investor Funding Round
UCB Series C